key: cord-0719345-flc5f9wh authors: Baral, S. D.; Rucinski, K. B.; Twahirwa Rwema, J. O.; Rao, A.; Prata Menezes, N.; Diouf, D.; Kamarulzaman, A.; Phaswana-Mafuya, N.; Mishra, S. title: The Relationship between the Global Burden of Influenza from 2017-2019 and COVID-19 date: 2020-06-20 journal: nan DOI: 10.1101/2020.06.18.20134346 sha: 29421c744dc0b8692da1ba0ca08ba2f5c97e515c doc_id: 719345 cord_uid: flc5f9wh Background SARS-CoV-2 and Influenza are lipid-enveloped viruses with differential morbidity and mortality but shared modes of transmission. We assessed whether historical patterns of regional influenza burden are reflected in the observed heterogeneity in COVID-19 cases across and within regions of the world. Methods Weekly surveillance data reported in FluNet from January 2017-December 2019 for influenza and World Health Organization for COVID-19 (to May 31, 2020) across the seven World Bank regions were used to assess the total and annual number of influenza and COVID-19 cases per country, within and across all regions, to generate comparative descending ranks from highest to lowest burden of disease. Results Across and within regions, rankings of influenza and COVID-19 were relatively consistent. Europe and Central Asia and North America ranked first and second for COVID-19 and second and first for influenza, respectively. East Asia and the Pacific traditionally ranked higher for influenza but to date, has been less affected by COVID-19. Between regions, Sub-Saharan Africa ranked amongst the least affected by both influenza and COVID-19. Conclusion Consistency in distribution of the burden of COVID-19 and influenza suggest shared individual, structural, and environmental determinants of transmission. Regions with discrepancies between influenza and COVID-19 burden may provide further insight into the potential impact of non-pharmacologic interventions and intersections with environmental conditions. Ultimately, forecasting trends and informing interventions for novel respiratory pathogens like COVID-19 should leverage patterns in the relative burden of past respiratory pathogens and the relative impact of non-pharmacologic intervention strategies as prior information. The COVID-19 pandemic has affected each region of the world differently 1 . As of June, 2020, Europe and the Americas regions have registered the highest numbers of COVID-19 cases and deaths while South-East Asia, Sub-Saharan Africa, and the Western Pacific have experienced comparatively milder epidemics 1 . Heterogeneity in COVID-19 burden has also been observed within cities, across cities, and across regions within a country 2, 3 . This heterogeneity likely stem from differences in underlying population structure with respect to age distribution, population and housing density, access to health care, burden of comorbidities, socio-economic and structural barriers to engagement in health, and the breadth and intensity of public health interventions. Furthermore, there remains active investigation into the heterogeneity of effects of both COVID-19 and the associated response on potential syndemics including infectious diseases such as HIV and tuberculosis and non-communicable conditions including mental health, reproductive health, and non-communicable diseases. Similar to SARS-CoV-2, influenza is a lipid-enveloped respiratory virus but with a more established evidence base for both effective non-pharmacologic intervention strategies and transmission dynamics [4] [5] [6] . Importantly, influenza is associated with a shorter incubation period and with lower mortality than the currently estimated SARS-CoV-2 infection case fatality rate 7, 8 . The relative risks of indoor vs. outdoor transmission, risks for contact, droplet-based, and aerosolization-mediated transmission are better established for influenza [9] [10] [11] . Influenza seasonality and spatial distribution are not fully understood but likely reflect individual, population, and environmental determinants 12 . Moreover, the annual burden and associated mortality secondary to pandemic and non-pandemic seasonal influenza strains vary significantly. The 2009 H1N1 pandemic was estimated to cause over 60 million cases in the United States, but resulted in higher mortality among youth but fewer deaths overall as older people were more likely to be immune 13 . In 2017, there were an estimated 45 million cases of mostly H3N2 and Influenza B in the United States but associated with higher mortality particularly among older adults given limited pre-existing immunity and limited vaccine effectiveness 14 . Environmental factors have been shown to explain in part the differences in influenza seasonality between temperate regions where cases peak during winter months, while tropical regions may have multiple peaks or intermittent influenza activity 15,16 . However, even within specific regions, some countries show influenza transmission patterns that are distinct from regional trends 17,18 . There have been early reports suggesting shared determinants of infection between influenza and SARS-CoV-2. In the United States, there is evidence of higher COVID-19 incidence, morbidity and mortality among African American communities secondary to underlying inequities including structural racism 19 . These racial disparities were also observed during the 2009 H1N1 influenza pandemic with similar drivers including higher risk of exposure due to inability to social distance, higher burden of comorbidities and limited access to health care among African American and other racialized communities [20] [21] [22] . Similarly, the early trajectories of COVID-19 and 2009 H1N1 have been noted in South Africa 23 . When this novel coronavirus emerged in early 2020, regional and national forecasting exercises drew on emerging data on the trajectory of detected cases of COVID-19 in the epicenters of China and Italy to translate their reproductive rates into best-and worst-case scenarios for local populations. That is, despite early comparison of the average mortality of influenza and SARS-CoV-2, there has not been a systematic evaluation of whether historical distributions in influenza burden are relevant in the prediction of the burden and distribution of SARS-CoV-2 infection. In this study, we comprehensively investigated global influenza transmission patterns from 2017 onwards to assess shared trends with the epidemiology of COVID-19. We used publicly available data to characterize temporal patterns of influenza across seven regions between 2017 and 2019. Organization of countries into regions was based on World Bank classifications, namely: East Asia and the Pacific, Europe and Central Asia, Latin America and the Caribbean, Middle East and North Africa, North America, South Asia, and sub-Saharan Africa. Within each region, we assessed country-specific weekly reported cases of influenza, including both Influenza A and B, from 1 January 2017 to 31 December 2019. Data were abstracted from FluNet, a global web-based tool developed by the World Health Organization for influenza virological surveillance, which captures weekly laboratory confirmed influenza cases. FluNet aggregates data from the National Influenza Centres of the Global Influenza Surveillance and Response System and other national influenza reference laboratories. Since more temperate zones in the Northern and Southern Hemispheres have generally opposing seasonal influenza trends, we report influenza case counts by calendar year from January 1 to December 31; which also facilitates comparisons with COVID-19. Finally, influenza case counts for the calendar year of 2020 were excluded given that public health measures focused on COVID-19 prevention and mitigation likely significantly decreased seasonal influenza cases for this time period 24 . We assessed patterns of missing data for each country and by year to determine eligibility for inclusion in analyses. For each year, countries where ≥ 90% of available weekly case reports were complete (assessed as the total number of non-missing records over the total number of all included weeks for that year) were included in analyses. For countries where data were <90% complete, we made the following determination: Countries where data missingness appeared to follow a seasonal pattern (e.g, data were missing only for weeks outside of the known influenza season, likely reflecting country-specific seasonal influenza reporting guidelines) were retained in analyses. Countries where weekly case counts were <90% complete and did not appear to follow a seasonal pattern, were denoted as missing. We assessed the overall burden of influenza for all included countries across and within each region. To do so, we summed the absolute number of influenza cases for each region, country and year (January 1 to December 31 of each year) given the temporal variability in influenza seasons around the world. Regions were ranked in descending order from highest to lowest number of absolute cases for 2017, 2018, and 2019. Countries were similarly ranked within regions, and overall, for each year. For each region, we plotted weekly influenza cases for the five highest ranked countries on a linear scale. Plots were visually inspected to assess for presence of temporal patterns within and across regions. We focused on case counts rather than per-capita rates given the concentration of both burden and testing generally in urban centers. Thus, using the entire country as a denominator inherently masks heterogeneity in the burden of infection within that country. Moreover, the relative proportion of the population residing in urban centers varies by country and by region, further challenging comparisons using per-capita rates. We further included analyses with ranks for influenza also created based on the total number of influenza cases reported for the first 20 weeks of each year (January 1 to May 31), as well as the total number of annual cases per capita of the country's population assuming stable population sizes from 2017-2019. We assessed, and similarly ranked, in descending order, cumulative cases of COVID-19 as reported through 31 May, for each region. Countries were also ranked within their respective regions and overall. We used rankings derived from COVID-19 case counts to anchor cross-pathogen comparisons. The seven World Bank regions were ranked in descending order by total COVID-19 burden. We utilized heat maps to visually represent differences in rank order of regions across influenza years. We employed similar methods to compare rank order of countries within regions and overall. By region, we used heat maps to compare the rank order of the top 15 countries with highest reported COVID-19 burden, to their order in rankings of total influenza cases in 2017, 2018, and 2019, separately. We described similarities or differences across and within all regions. Influenza cases were assessed for 171 countries. For each year, more than half (ranging from 55.6%-56.7%) of all countries reported ≥ 90% complete data (Supplemental Table 1 ). The proportion of countries where data were <90% complete, but followed a pattern of seasonal missingness were also included in influenza analyses, ranged from 22.8% in 2017 to 24.0% in 2019. Differences in data completion and patterns of missingness were evident across all regions. The overall influenza burden between 2017 and 2019 varied by region and by countries within all seven identified regions (Table 1) . Regions with the highest absolute burden of influenza included North America (903,554 cases), Europe and Central Asia (599,820 cases), and East Asia and the Pacific (389,657 cases). Countries with the highest proportion of regional influenza cases were as follows: East Asia and the Pacific (China; 77.5%); Europe and Central Asia (the United Kingdom; 17.7%), Latin America and the Caribbean (Mexico, 20.2%), Middle East and In this study, we found ecological consistency between the burden of influenza from 2017-2019 and the recorded number of COVID-19 cases to date. Specifically, North America, Europe and Central Asia generally reported the highest numbers of influenza cases per year and have also had the highest the highest burden of COVID-19. Outside of East Asia and the Pacific, regions with lower levels of COVID-19 generally ranked lower in influenza burden using historical data. East Asia and the Pacific ranked third in 2017-2019 for influenza burden but is ranked second last above Sub-Saharan Africa for COVID-19. Within regions, there was also general consistency between countries that generally ranked higher in historical influenza cases and those with higher COVID-19 case counts. The ecological consistency in the burden of COVID-19 and the recent burden of influenza is suggestive of likely shared individual, structural, and environmental determinants of infection. Outside of public health interventions, there is generally less consensus on the determinants that potentiate or inhibit COVID-19 transmission. However, given decades of study, there is more information available on the individual, population-level, and environmental determinants of influenza. At the individual level, underlying immunity is related to previous exposure to similar strains and vaccine uptake and effectiveness. Effectiveness of vaccines depends on circulating influenza strains i.e pandemic and non-pandemic, or seasonal; secondary to antigenic drift and shift of influenza viruses. Population-level characteristics include vaccine coverage and shield immunity, population density, social norms, and health care infrastructure. Finally, environmental factors affecting influenza include temperature, air pollution, and humidity 25,26 . Given how rapidly COVID-19 has emerged, conclusions of different studies exploring the role of environmental conditions have differed significantly. One study found no associations between latitude and temperature with COVID-19 epidemic growth using a two-week exposure period in March across 144 geopolitical areas 27 . However, a "living" review leveraging data from December, 2019 onwards from nearly 4000 locations across the world showed significant differences in COVID-19 burden associated with temperature, humidity, pollution, and other environmental factors 28 . Collectively, these studies suggest the potential for at least some seasonal variation secondary to changes in environmental conditions in the transmission of SARS-CoV-2 similar to other respiratory pathogens, including influenza and other seasonal coronaviruses 29-32 . Influenza seasonality is more pronounced in more temperate areas of the Northern and Southern hemispheres consistent with opposing fall and winter seasons. A recent assessment of the seasonality of infectious pathogens included individual-level determinants. such as growing immunity throughout an influenza season secondary to vaccination or exposure, that results in achieving effective levels of shield immunity limiting transmission 33 . There has been some study of existing immunity to COVID-19 mediated via cross-reactivity with other coronaviruses 33,34 . However, lesser population-wide immunity could mean sustained transmission even during times with less transmission of other respiratory pathogens. Influenza seasonality may also be secondary to population-level changes including potentially higher crowding in colder weathers, increased use of respite care and housing, people returning to work and school, and . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted June 20, 2020. . increased use of transit services that may collectively facilitate transmission. Environmental conditions may further affect individual susceptibility to infection as well as contact or respiratory droplet transmission patterns. The recent increases in COVID-19 in late May and early June in some areas of the Southern hemisphere including countries across South America are consistent with the timing of the traditional influenza season 35 . Moreover, in South Africa, epicenters of COVID-19 appear to be similar to areas with increased influenza transmission 36,37 . In the less temperate areas of Sub-Saharan Africa and Southeast Asia, influenza burden appears to be generally lower. While there is likely a relationship between testing infrastructure and influenza reporting, the consistency in the COVID-19 and influenza burden among countries within each region was notable. East Asia and the Pacific is an exception here with generally higher burdens of influenza and more limited COVID-19 cases. Given that COVID-19 emerged in this region, non-pharmacologic interventions widely implemented and shown to have affected both COVID-19 and influenza burden may explain this finding 24 . In addition, while influenza is endemic in several countries, rapidly decreasing introduction of COVID-19 through the closure of borders likely played a critical role especially in settings experiencing traditional influenza season. A hallmark of COVID-19 has been the role of social determinants of health with socioeconomic status, living conditions, access to health care, and underlying comorbidities being consistent predictors of COVID-19 incidence and mortality around the world 38,39 . Moreover, structural racism has been documented in several settings including the United States, United Kingdom, and Canada, but likely relevant in many more settings not reporting on racial identity of those affected 40,41 . Notably, similar disparities were observed in the 2009 H1N1 pandemic in the United States though there has been limited documentation of socioeconomic disparities of influenza in most settings 20,42 . While disparities are well documented for other infectious diseases such as HIV, these disparities evolve across cycles of transmission spanning years. Given how rapidly disparities emerged with COVID-19, interventions to address disparities may be observable over shorter time horizons and provide insight into effective interventions to address pervasive social health inequities. Secondary to intersections of differential access to health care and medical mistrust, the development of a generally effective vaccine has not mitigated disparities 43-45 . Leveraging frameworks focused on optimizing implementation of influenza vaccination strategies including increased equity will be critical in informing SARS-CoV-2 vaccines when available 46,47 . COVID-19 is also rapidly increasing our understanding of post-viral morbidities including cardiovascular complications 48 . While post-viral complications have been described for other viruses, the mechanisms of consequences may be elucidated based on the research into COVID-19 broadening the potential impact of these studies 49-53 . This study has several limitations. Risk of ecological fallacy is relevant where individuals in generally lower ranking regions or countries may have high risks of acquisition and transmission secondary to micro-epidemics, including in those in congregate living settings, refugee and migrant work camps, long term care facilities, homeless shelters, and prisons. Missingness in data aggregated by FluNet is another limitation. We assumed that countries where influenza data was missing in a seasonal pattern was a reflection of very few case counts and/or reduced reporting outside of the typical influenza season, and indeed seasonal "missingness" was most apparent for countries in the European region, where the influenza season has been well documented. However, by excluding countries with > 10% data missingness that did not follow a . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 20, 2020. . seasonal influenza pattern, several sub-Saharan African countries (e.g. Sudan) were not included in the comparison of rankings despite high COVID-19 and influenza burden. Absolute influenza and COVID-19 case counts were reported, rather than positivity rates given that testing eligibility and subsequent testing rates may have varied dramatically within and across countries. Biases present in interpreting positivity rates, such as availability of infrastructure to implement broad testing strategies, may be reflected in total number of case counts, across both influenza and COVID-19. The results presented here suggest that the distribution in the global burden of COVID-19 reflects that of influenza. This ecological overlap suggests that the underlying dynamics of transmission of influenza and COVID-19 are similar as they relate to spatial, seasonal, population structure and the disparities that lead to disproportionate vulnerabilities in various population groups. In considering the host-pathogen-environment framework commonly used for infectious diseases, emerging infections represent novel pathogens, but the populations and environment under which they emerge and spread are the same. Similarly, the similarities observed here suggest the potential utility of informing COVID-19 prevention and mitigation interventions with the vast data available characterizing critical issues including the relative risks of indoor vs. outdoor transmission, risks of aerosolization for influenza, and even optimal delivery of vaccines and chemoprophylaxis and treatment strategies when developed. Ultimately, regional and national public health systems preparing and responding to the current and future waves of COVID-19 may benefit from evaluating the relative burden of past respiratory pathogens and the impact of non-pharmacologic intervention strategies as prior information when forecasting and implementing interventions. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 20, 2020. . . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 20, 2020. . is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 20, 2020. . R e g i o n C O V I D -1 9 2 0 1 9 I n f l u e n z a 2 0 1 8 I n f l u e n z a 2 0 1 7 I n f l u e n z . It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 20, 2020. . . It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 20, 2020. It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 20, 2020. . It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 20, 2020. . is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 20, 2020. . C a l e d o n i a C a l e d o n i a K o r e a , D e m . P e o p l e ' s R e p . 8 5 1 0 . 2 P h i l i p p i n e s 3 4 6 0 . 2 C a m b o d i a 2 3 4 0 . 2 C a m b o d i a 2 2 6 0 . 2 S o u t h A s i a 3 1 , 9 9 2 1 0 0 . 0 1 7 , 3 1 3 1 0 0 . 0 5 , 4 0 1 1 0 0 . 0 9 , 2 7 8 1 0 0 . 0 I n d i a 1 4 , 8 9 5 4 6 . 6 I n d i a 1 0 , 4 2 8 6 0 . 2 I n d i a 1 , 8 8 0 3 4 . 8 I n d i a 2 , 5 8 7 2 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 20, 2020. N o r t h A m e r i c a 9 0 3 , 5 5 4 1 0 0 . 0 3 1 0 , 7 2 4 1 0 0 . 0 3 3 4 , 0 9 3 1 0 0 . 0 2 5 8 , 7 3 7 1 0 0 . 0 U n i t e d S t a t e s o f A m e r i c a 7 4 9 , 4 7 2 8 2 . 9 U n i t e d S t a t e s o f A m e r i c a 2 6 7 , 5 2 8 8 6 . 1 U n i t e d S t a t e s o f A m e r i c a 2 6 7 , 6 1 1 8 0 . 1 U n i t e d S t a t e s o f A m e r i c a 2 1 4 , 3 3 3 8 2 . 8 C a n a d a 1 5 4 , 0 8 2 1 7 . 1 C a n a d a 4 3 , 1 9 6 1 3 . 9 C a n a d a 6 6 , 4 8 2 1 9 . 9 C a n a d a 4 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 20, 2020. . C O V I D -1 9 c a s e s % o f r e g i o n a l t o t a l S u b -S a h a r a n A f r i c a 9 5 , 8 4 5 1 0 0 . 0 S o u t h A f r i c a 3 0 , 9 6 7 3 2 . 3 N i g e r i a 9 , 8 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 20, 2020. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 20, 2020. COVID-19 situation report -133. World Health Organization Regional differences in Covid-19 transmission rate emerge in England. The Guardian Geographic Differences in COVID-19 Cases, Deaths, and Incidence -United States Effectiveness of workplace social distancing measures in reducing influenza transmission: a systematic review Effectiveness of N95 respirators versus surgical masks against influenza: A systematic review and meta-analysis Rational use of face masks in the COVID-19 pandemic Incubation periods of acute respiratory viral infections: a systematic review Real estimates of mortality following COVID-19 infection. The Lancet Infectious Diseases g a l 3 2 , 2 0 3 1 . 5 S w i t z e r l a n d 3 0 , 7 6 2 1 . 5 I r e l a n d 2 4 , 9 2 9 1 . 2 U k r a i n e 2 3 , 6 7 2 1 . 1